Forty-Five Years After the Discovery of the Hepatitis D Virus: Where Do We Stand?

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2021 Apr 3

PMID 33810224

Citations 3

Authors

Mario Rizzetto

Tommaso Stroffolini

Affiliations

Soon will be listed here.

Abstract

The discovery of the Australia Antigen in the mid-1960s led, in a few years, to the identification of the virus of Hepatitis B [...].

Citing Articles

Current prevalence of hepatitis delta diagnosis in Valencia, Spain.

Ortega Gonzalez E, Ocete Mochon M, Martinez-Roma M, Gimeno Cardona C, Gomez Munoz N, Diago Madrid M Sci Rep. 2025; 15(1):7584.

PMID: 40038382 PMC: 11880328. DOI: 10.1038/s41598-025-91765-8.

Apulian infectious diseases network: survey on the prevalence of delta infection among chronic HBV carriers in Apulia.

Fasano M, Milella M, Carbonara S, Tundo P, Minniti S, Buccoliero G Front Public Health. 2023; 11:1247454.

PMID: 37822539 PMC: 10562714. DOI: 10.3389/fpubh.2023.1247454.

Epidemiology Pattern, Prevalent Genotype Distribution, Fighting Stigma and Control Options for Hepatitis D in Bulgaria and Other European Countries.

Tsaneva-Damyanova D, Georgieva L Life (Basel). 2023; 13(5).

PMID: 37240760 PMC: 10222293. DOI: 10.3390/life13051115.

Oral and Periodontal Implications of Hepatitis Type B and D. Current State of Knowledge and Future Perspectives.

Gheorghe D, Bennardo F, Popescu D, Nicolae F, Ionele C, Boldeanu M J Pers Med. 2022; 12(10).

PMID: 36294719 PMC: 9604856. DOI: 10.3390/jpm12101580.

References

Wedemeyer H, Manns M . Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol. 2010; 7(1):31-40. DOI: 10.1038/nrgastro.2009.205. View

Stroffolini T, Ciancio A, Furlan C, Vinci M, Fontana R, Russello M . Migratory flow and hepatitis delta infection in Italy: A new challenge at the beginning of the third millennium. J Viral Hepat. 2020; 27(9):941-947. DOI: 10.1111/jvh.13310. View

Rizzetto M, Hamid S . The medical impact of hepatitis D virus infection in Asia and Africa; time for a reappraisal. Liver Int. 2020; 41(1):16-19. DOI: 10.1111/liv.14729. View

Miao Z, Zhang S, Ou X, Li S, Ma Z, Wang W . Estimating the Global Prevalence, Disease Progression, and Clinical Outcome of Hepatitis Delta Virus Infection. J Infect Dis. 2019; 221(10):1677-1687. PMC: 7184909. DOI: 10.1093/infdis/jiz633. View

Cabezas C, Trujillo O, Balbuena J, Terrazas M, Manrique-de Lara C, Marin L . [Reduction of HBV and HDV infection in two indigenousmpeoples of Peruvian Amazon after the vaccination against hepatitis B]. Salud Publica Mex. 2020; 62(3):237-245. DOI: 10.21149/11128. View

Rizzetto M, Bonino F, Crivelli O, Canese M, Verme G . Complement fixing hepatitis B core antigen immune complexes in the liver of patients with HBs antigen positive chronic disease. Gut. 1976; 17(11):837-43. PMC: 1411205. DOI: 10.1136/gut.17.11.837. View

Wedemeyer H, Heidrich B, Manns M . Hepatitis D virus infection--not a vanishing disease in Europe!. Hepatology. 2007; 45(5):1331-2. DOI: 10.1002/hep.21590. View

Rizzetto M, Canese M, Arico S, Crivelli O, Trepo C, Bonino F . Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut. 1977; 18(12):997-1003. PMC: 1411847. DOI: 10.1136/gut.18.12.997. View

Manesis E, Vourli G, Dalekos G, Vasiliadis T, Manolaki N, Hounta A . Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study. J Hepatol. 2013; 59(5):949-56. DOI: 10.1016/j.jhep.2013.07.005. View

10.

Lin G, Wu Y, Wang C, Ko C, Chen C, Chen P . Performance of commercially available anti-HDV enzyme-linked immunosorbent assays in Taiwan. Virol J. 2020; 17(1):76. PMC: 7298757. DOI: 10.1186/s12985-020-01355-5. View

11.

Taylor J . Infection by Hepatitis Delta Virus. Viruses. 2020; 12(6). PMC: 7354607. DOI: 10.3390/v12060648. View

12.

Coghill S, McNamara J, Woods M, Hajkowicz K . Epidemiology and clinical outcomes of hepatitis delta (D) virus infection in Queensland, Australia. Int J Infect Dis. 2018; 74:123-127. DOI: 10.1016/j.ijid.2018.07.005. View

13.

Rizzetto M, Hoyer B, Canese M, Shih J, Purcell R, Gerin J . delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. Proc Natl Acad Sci U S A. 1980; 77(10):6124-8. PMC: 350226. DOI: 10.1073/pnas.77.10.6124. View

14.

Servant-Delmas A, Le Gal F, Gallian P, Gordien E, Laperche S . Increasing prevalence of HDV/HBV infection over 15 years in France. J Clin Virol. 2013; 59(2):126-8. DOI: 10.1016/j.jcv.2013.11.016. View

15.

Chen H, Shen D, Ji D, Han P, Zhang W, Ma J . Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis. Gut. 2018; 68(3):512-521. DOI: 10.1136/gutjnl-2018-316601. View

16.

Chang W, Pettersson J, Le Lay C, Shi M, Lo N, Wille M . Novel hepatitis D-like agents in vertebrates and invertebrates. Virus Evol. 2019; 5(2):vez021. PMC: 6628682. DOI: 10.1093/ve/vez021. View

17.

Caviglia G, Martini S, Ciancio A, Niro G, Olivero A, Fontana R . The hepatitis D virus in Italy. A vanishing infection, not yet a vanished disease. J Adv Res. 2021; 33:183-187. PMC: 8463926. DOI: 10.1016/j.jare.2021.02.009. View

18.

Patel E, Thio C, Boon D, Thomas D, Tobian A . Prevalence of Hepatitis B and Hepatitis D Virus Infections in the United States, 2011-2016. Clin Infect Dis. 2019; 69(4):709-712. PMC: 6669285. DOI: 10.1093/cid/ciz001. View

19.

Cuenca-Gomez J, Salas-Coronas J, Soriano-Perez M, Vazquez-Villegas J, Lozano-Serrano A, Cabezas-Fernandez M . Viral hepatitis and immigration: A challenge for the healthcare system. Rev Clin Esp (Barc). 2016; 216(5):248-52. DOI: 10.1016/j.rce.2016.02.005. View

20.

Aguilera A, Trastoy R, Barreiro P, Costa J, de Mendoza C, Pena J . Decline and changing profile of hepatitis delta among injection drug users in Spain. Antivir Ther. 2017; 23(1):87-90. DOI: 10.3851/IMP3161. View